Socías ME, Dickhout P, Langlois J, Grant C, Nolan S Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: the FASTER-BUP udy [sic] Drug Alcohol Depend PubMed

Jackson E, Bach P, Socías ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis B Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: findings from a prospective cohort study from 2013 to 2020 Drug Alcohol Depend PubMed

Crepeault H, Cowan N, Socías ME, Riazi N, Knill A, Khela A, Wood E, Ti L Applying a modified version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian community withdrawal management setting Drug Alcohol Rev PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J PubMed

Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon B, Socías ME Use of buprenorphine/naloxone in an adult with cystic fibrosis Can J Hosp Pharm PubMed

Anand R, Penta S, Cui Z, Fairbairn N, Socías ME Redesigning a stopped clinical trial as an emulated trial using real-world data to explore the effectiveness of slow-release oral morphine as a treatment for opioid use disorder Subst Use Addctn J PubMed

Kitchen C, Socías ME, Sayre EC, Hayashi K, DeBeck K, Milloy MJ, Kerr T, Reddon H Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain Drug Alcohol Rev PubMed

Crepeault H, Ti L, Bach P, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Socías ME Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: findings from a pragmatic, pan-Canadian, randomized control trial Am J Addict PubMed

Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME Buprenorphine/naloxone vs methadone for the treatment of opioid use disorder JAMA PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Lim R, Socías ME Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada Am J Addict PubMed